Literature DB >> 16479314

Diagnostic value of C-reactive protein in discriminating fungal from nonfungal pulmonary infiltrates in patients with hematologic malignancies.

Massimo Offidani1, Laura Corvatta, Lara Malerba, Maria-Novella Piersantelli, Esther Manso, Pietro Leoni.   

Abstract

The objective of this study was to assess the utility of C-reactive protein (CRP) on differential diagnosis of pulmonary infiltrates occurring in 143 febrile patients with hematologic malignancies. Serum CRP level, measured on the first day of pneumonia, was significantly higher in patients with fungal lung infiltrates than in those with nonfungal pneumonia (22.3 mg/dl vs 7.3 mg/dl; p<0.0001). Predictive factors for fungal pneumonia were CRP level higher than 10 mg/dl, neutropenia longer than 10 days, and active underlying disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479314     DOI: 10.1007/s00520-006-0030-0

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  12 in total

1.  Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia.

Authors:  E J Giamarellos-Bourboulis; P Grecka; G Poulakou; K Anargyrou; N Katsilambros; H Giamarellou
Journal:  Clin Infect Dis       Date:  2001-05-21       Impact factor: 9.079

2.  Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation.

Authors:  A B-T Fassas; M H Miceli; M Grazzlutti; L Dong; B Barlogie; E Anaissie
Journal:  Leuk Lymphoma       Date:  2005-08

3.  Procalcitonin--a marker of invasive fungal infection?

Authors:  H J Dornbusch; V Strenger; R Kerbl; H Lackner; W Schwinger; P Sovinz; C Urban
Journal:  Support Care Cancer       Date:  2005-01-19       Impact factor: 3.603

4.  Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients.

Authors:  M Svaldi; J Hirber; A I Lanthaler; O Mayr; S Faes; E Peer; M Mitterer
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

5.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Authors:  S Ascioglu; J H Rex; B de Pauw; J E Bennett; J Bille; F Crokaert; D W Denning; J P Donnelly; J E Edwards; Z Erjavec; D Fiere; O Lortholary; J Maertens; J F Meis; T F Patterson; J Ritter; D Selleslag; P M Shah; D A Stevens; T J Walsh
Journal:  Clin Infect Dis       Date:  2001-11-26       Impact factor: 9.079

6.  Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation.

Authors:  Mar Ortega; Montserrat Rovira; Xavier Filella; Manel Almela; Jorge Puig de la Bellacasa; Enric Carreras; Josep Mensa
Journal:  Br J Haematol       Date:  2004-08       Impact factor: 6.998

7.  Risk assessment of patients with hematologic malignancies who develop fever accompanied by pulmonary infiltrates: a historical cohort study.

Authors:  Massimo Offidani; Laura Corvatta; Lara Malerba; Monica Marconi; Elisabetta Bichisecchi; Sara Cecchini; Esther Manso; Tiziana Principi; Stefano Gasparini; Pietro Leoni
Journal:  Cancer       Date:  2004-08-01       Impact factor: 6.860

8.  Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation.

Authors:  M Ortega; M Rovira; M Almela; J P de la Bellacasa; E Carreras; J Mensa
Journal:  Bone Marrow Transplant       Date:  2004-04       Impact factor: 5.483

9.  A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia.

Authors:  F A Manian
Journal:  Clin Infect Dis       Date:  1995-07       Impact factor: 9.079

10.  An early increase in serum levels of C-reactive protein is an independent risk factor for the occurrence of major complications and 100-day transplant-related mortality after allogeneic bone marrow transplantation.

Authors:  R Schots; I Van Riet; T Ben Othman; F Trullemans; M De Waele; B Van Camp; L Kaufman
Journal:  Bone Marrow Transplant       Date:  2002-10       Impact factor: 5.483

View more
  1 in total

Review 1.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.